Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Healthcare Bull 3X Shares

140.37
+3.322.43%
Volume:33.19K
Turnover:4.69M
Market Cap:189.50M
PE:- -
High:143.56
Open:138.86
Low:138.86
Close:137.05
52wk High:150.00
52wk Low:74.34
Shares:1.35M
Float Shares:1.35M
Volume Ratio:1.00
T/O Rate:2.46%
Dividend:1.27
Dividend Rate:0.90%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Aspen Bets on Manufacturing Rebound, Obesity Drug Push for Growth

Reuters
·
Yesterday

World's Largest Companies by Market Cap (August 2026): Nvidia Retains Top Spot, SpaceX Rebounds 32%, Semiconductor Sector Diverges

TradingKey
·
Yesterday

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 01

Eli Lilly (LLY) Eyes Merida Deal As Trial Data Strengthens Autoimmune Push

Simply Wall St.
·
Sep 01

Dow Jones Top Company Headlines at 9 PM ET: Anthropic Signs $35 Billion Cloud Deal Backed by Nvidia | UPS ...

Dow Jones
·
Sep 01

1 Weight Loss Drugs Effective Even at Low Starter Doses

Reuters
·
Sep 01

Dow Jones Top Company Headlines at 5 PM ET: FTC Files Lawsuit Alleging Amazon Deceived Advertisers | State ...

Dow Jones
·
Sep 01

Ataibeckley - Hart-Scott-Rodino Waiting Period for Merger with Eli Lilly Expired on Aug 28, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 01

Sector Update: Healthcare Stocks Decline Monday Afternoon

MT Newswires Live
·
Sep 01

Moderately bullish activity in Eli Lilly with shares down 1.26%

TIPRANKS
·
Sep 01

Top Midday Stories: Stocks Fall, Oil Rises Amid Renewed Fighting in Middle East; Utility Shares Fall After California Wildfire Legislation

MT Newswires Live
·
Aug 31

Dow Jones Top Company Headlines at 11 am ET: GameStop Sees Higher Profit as eBay Investment Offsets Lower Sales | SLB ...

Dow Jones
·
Aug 31

Eli Lilly Expands Beyond Weight-Loss Dominance With Potential $2.88B Autoimmune Deal

Stock News
·
Aug 31

Lilly is Bigger than Ever. Why Its Latest $2.9 Billion Immunology Deal Makes Sense.

Dow Jones
·
Aug 31

Eli Lilly's Psoriasis Drug Trial Shows Sustained Positive Results

Dow Jones
·
Aug 31

Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What it Means for the Stock.

Dow Jones
·
Aug 31

Eli Lilly announces 52-week results from TOGETHER-PsO, TOGETHER-PsA

TIPRANKS
·
Aug 31

Eli Lilly - Taltz and Zepbound Lead to Deeper Improvements in Systemic Inflammation in Both Trials

THOMSON REUTERS
·
Aug 31

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Used Together Showed Improved and Durable Efficacy at One Year in Adults with Psoriatic Disease and Obesity

THOMSON REUTERS
·
Aug 31